The prior Series B round was led by Indonesia’s MDI Ventures with participation from other global investors, including the Bill & Melinda Gates Foundation, Johnson & Johnson Impact Ventures, SIG, and other existing investors. We announced the raise of its US$27 million Series B round in May 2022. Existing investors Susquehanna International Group (SIG), Johnson & Johnson, and Patamar Capital also participated. This round marks investments from marquee investors such as global pharma Sanofi’s Global Health Unit and Cercano Management (formerly Microsoft co-founder Paul Allen’s Vulcan Capital). SwipeRx has secured $10 million in fresh funds as part of a new Series B2 round. Today I am excited to announce the news of our USD$37 Million Series B Fundraise.
0 kommentar(er)
